State Governments Are Jumping on the Biotech and Genetic Testing Bandwagon
Clinical laboratory managers and pathologists can expect more personalized medicine products and services as biotech industry flourishes
Its gold rush time in biotech. Because of the promise of biotechnology to improve patient outcomes—and deliver lots of good-paying, clean jobs, even states are competing to attract the top scientists and companies who conduct research into genetics, molecular diagnostics, and healthcare informatics.
This is an auspicious trend for the medical laboratory testing industry. Among other things, innovations in biotechnology are expected to find application in clinical laboratory tests that improve the diagnostic capabilities of pathologists. Biotech underpins genetic medicine and will fuel advances in personalized medicine. (more…)
